Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial membranes and lipopolysaccharides (LPS) are fundamental structural elements of the diverse microbial communities residing in oral biofilms, such as dental plaque. LPS, a potent endotoxin found in the outer membrane of Gram-negative bacteria, is a primary driver of the inflammatory response in periodontal tissues by activating the Toll-like receptor 4 (TLR4) pathway (Raetz & Whitfield, 2002; Darveau, 2010). The bacterial cell membrane serves as a critical barrier and a site for metabolic processes, making its disruption a key strategy for antimicrobial therapy. Therapeutic agents like chlorhexidine and cetylpyridinium chloride target these structures through electrostatic interactions, leading to membrane destabilization and the leakage of essential intracellular components (StatPearls, 2023). By neutralizing LPS and compromising membrane integrity, these treatments effectively reduce the virulence and viability of pathogens associated with gingivitis and periodontitis (Marsh, 2004). Consequently, these components are central to both the pathogenesis of oral diseases and the mechanism of action for many common dental antiseptics. Targeting these structures helps prevent the progression of tissue destruction and the potential systemic dissemination of oral pathogens.
Antimicrobial agents typically target these structures by binding to negatively charged components, such as the phosphate groups in LPS or phospholipids, which leads to membrane permeabilization, leakage of cytoplasmic contents, and cell death. Additionally, some agents can sequester or neutralize the lipid A moiety of LPS, thereby preventing its interaction with host immune receptors like TLR4 and reducing the subsequent inflammatory cascade (Raetz & Whitfield, 2002; StatPearls, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial lipopolysaccharide and cell membrane (LPS).